MASS official logo MASS
MASS 1-star rating from Upturn Advisory
908 Devices Inc (MASS) company logo

908 Devices Inc (MASS)

908 Devices Inc (MASS) 1-star rating from Upturn Advisory
$5.4
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

01/06/2026: MASS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

4 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $10

1 Year Target Price $10

Analysts Price Target For last 52 week
$10 Target price
52w Low $1.92
Current$5.4
52w High $9.34

Analysis of Past Performance

Type Stock
Historic Profit -30.77%
Avg. Invested days 18
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 01/06/2026

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 198.34M USD
Price to earnings Ratio -
1Y Target Price 10
Price to earnings Ratio -
1Y Target Price 10
Volume (30-day avg) 4
Beta 0.48
52 Weeks Range 1.92 - 9.34
Updated Date 01/6/2026
52 Weeks Range 1.92 - 9.34
Updated Date 01/6/2026
Dividends yield (FY) -
Basic EPS (TTM) -2.07

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -6.35%
Operating Margin (TTM) -40.1%

Management Effectiveness

Return on Assets (TTM) -16.43%
Return on Equity (TTM) -54.42%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 76524258
Price to Sales(TTM) 3.05
Enterprise Value 76524258
Price to Sales(TTM) 3.05
Enterprise Value to Revenue 1.18
Enterprise Value to EBITDA -3.15
Shares Outstanding 36192978
Shares Floating 22252167
Shares Outstanding 36192978
Shares Floating 22252167
Percent Insiders 8.32
Percent Institutions 90.87

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

908 Devices Inc

908 Devices Inc(MASS) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

908 Devices Inc. was founded in 2007 by a team of scientists from Harvard University, specializing in mass spectrometry. The company's mission is to democratize analytical chemistry by developing portable and easy-to-use mass spectrometry devices. Key milestones include the commercialization of their first product, the 908 Devices MX908, and subsequent introductions of other innovative devices for various applications. The company has evolved to focus on delivering high-performance, field-deployable mass spectrometry solutions.

Company business area logo Core Business Areas

  • High-Pressure Mass Spectrometry (HPMS) Solutions: This segment focuses on developing and selling advanced mass spectrometry instruments that utilize high-pressure techniques. These instruments are designed for rapid and precise chemical analysis in demanding environments, offering capabilities for detection and identification of trace substances.
  • Consumables and Services: This segment includes the sale of consumables (e.g., sample inlets, filters) required for the operation of their instruments, as well as offering services such as instrument maintenance, calibration, and customer support to ensure optimal performance and longevity of their products.

leadership logo Leadership and Structure

The leadership team at 908 Devices Inc. is comprised of experienced professionals in the fields of mass spectrometry, engineering, and business management. The company operates with a matrix structure, integrating R&D, engineering, sales, marketing, and operations to drive innovation and market penetration.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • MX908: A handheld, high-pressure mass spectrometer designed for rapid detection and identification of explosives, chemical warfare agents, and narcotics. It is widely used by first responders, military personnel, and hazmat teams. Competitors in this niche include companies like Smiths Detection and FLIR Systems (now Teledyne FLIR) with their portable detection technologies, though 908 Devices' specific HPMS technology offers a differentiated approach. Specific market share data for this single product is not publicly disclosed, but it is a flagship offering for the company.
  • M908: A portable mass spectrometer designed for environmental monitoring and industrial hygiene applications, enabling on-site analysis of volatile organic compounds (VOCs) and other airborne contaminants. Similar to the MX908, it competes with other portable analytical instruments. Market share is not precisely defined for this specific model, but it contributes to the company's overall presence in the portable analytical instrumentation market.
  • Traveler: A smaller, portable mass spectrometer aimed at laboratories and field applications for rapid sample analysis. It offers versatility for various analytical challenges. Competitors include a broad range of benchtop and portable mass spectrometry providers from companies like Agilent Technologies, Thermo Fisher Scientific, and Shimadzu.

Market Dynamics

industry overview logo Industry Overview

908 Devices operates within the analytical instrumentation market, specifically focusing on mass spectrometry. This industry is characterized by continuous innovation, demand for higher sensitivity, faster analysis times, and miniaturization for portability. Key application areas include environmental monitoring, homeland security, pharmaceutical research, and food safety.

Positioning

908 Devices is positioned as a leader in high-pressure mass spectrometry (HPMS) technology, offering portable and field-deployable solutions that differentiate it from traditional, larger laboratory-bound instruments. Its competitive advantages lie in its unique technology enabling rapid, on-site analysis with high sensitivity and specificity.

Total Addressable Market (TAM)

The global market for mass spectrometers is substantial and growing, with various estimates placing it in the billions of dollars. 908 Devices specifically targets segments within this market, such as portable detection systems and field-based analytical solutions. The company is positioned to capture a significant portion of the niche TAM for portable, high-performance mass spectrometry, leveraging its technological edge.

Upturn SWOT Analysis

Strengths

  • Proprietary High-Pressure Mass Spectrometry (HPMS) technology
  • Development of portable and field-deployable instruments
  • Strong intellectual property portfolio
  • Experienced management and scientific team
  • Established presence in defense and security markets

Weaknesses

  • Relatively smaller company size compared to major players
  • Dependence on a few key product lines
  • Need for continued investment in R&D to maintain technological lead
  • Potential challenges in scaling manufacturing and distribution globally

Opportunities

  • Expansion into new market segments (e.g., pharmaceutical, industrial)
  • Development of new applications for existing technologies
  • Strategic partnerships and collaborations
  • Increasing demand for real-time, on-site chemical analysis
  • Growth in emerging economies

Threats

  • Intensifying competition from established and emerging analytical instrument manufacturers
  • Technological obsolescence
  • Changes in government spending or regulatory policies
  • Economic downturns affecting customer budgets
  • Supply chain disruptions

Competitors and Market Share

Key competitor logo Key Competitors

  • Agilent Technologies (A)
  • Thermo Fisher Scientific (TMO)
  • Bruker Corporation (BRKR)

Competitive Landscape

908 Devices' competitive advantage lies in its specialized HPMS technology, offering unique portability and performance for niche applications. However, it faces intense competition from larger, established players with broader product portfolios, extensive distribution networks, and significant R&D budgets. The company needs to continue innovating and demonstrating clear value propositions to maintain its competitive edge.

Growth Trajectory and Initiatives

Historical Growth: 908 Devices has demonstrated a historical growth trajectory driven by its innovative technology and expansion into new markets. Revenue has seen an upward trend as the company increases its product adoption and customer base. This growth is supported by its strategy of targeting high-value applications in sectors like defense, security, and increasingly, commercial markets.

Future Projections: Future projections for 908 Devices Inc. are generally positive, with analysts anticipating continued revenue growth driven by market expansion and new product development. The company's focus on portable and advanced analytical solutions aligns with growing industry trends. Specific analyst estimates can be found in financial research reports.

Recent Initiatives: Recent initiatives likely include expanding its sales and marketing efforts, forging strategic partnerships to reach new customers and applications, investing in R&D to enhance its product portfolio, and potentially exploring new geographic markets.

Summary

908 Devices Inc. is a specialized player in the analytical instrumentation market, excelling in portable high-pressure mass spectrometry. The company's innovative technology offers a competitive edge in niche segments like defense and security. While its growth trajectory is promising, it faces challenges from larger competitors and requires sustained R&D investment. Key opportunities lie in market expansion and continued product development.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company Investor Relations Filings (e.g., SEC filings)
  • Financial news and analysis websites
  • Industry research reports

Disclaimers:

This JSON output is for informational purposes only and should not be considered investment advice. Financial data and market share estimations are subject to change and may not be entirely precise. Investors should conduct their own due diligence before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About 908 Devices Inc

Exchange NASDAQ
Headquaters Boston, MA, United States
IPO Launch date 2020-12-18
Co-Founder, CEO, President & Director Dr. Kevin J. Knopp Ph.D.
Sector Healthcare
Industry Medical Devices
Full time employees 246
Full time employees 246

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as process fingerprint data to support large-scale efforts in predictive bioprocess modeling. The company's products comprise Maven, an on-line device for bioprocess monitoring and control; Trace C2, an on-line monitoring of methanol or ethanol and control of substrate feeding in fermentation processes; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.